Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#81 / 100 Total
ONCT - Oncternal Therapeutics Inc - Stock Price Chart
TickerONCT [NASD]
CompanyOncternal Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap25.46MEPS (ttm)-13.43
P/E-EPS this Y20.59%
Forward P/E-EPS next Y20.86%
PEG-EPS past 5Y18.19%
P/S32.22EPS next 5Y0.00%
P/B0.84EPS Q/Q22.86%
Dividend-Sales Q/Q73.68%
Insider Own9.78%Inst Own14.13%
Insider Trans3.58%Inst Trans-72.82%
Short Float0.63%EarningsMar 07/a
Analyst Recom1.50Target Price31.33
Avg Volume10.46K52W Range5.57 - 13.14
Oncternal Therapeutics, Inc. engages in the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Its product pipeline include Zilovertamab, ONCT-216, ONCT-808 and ONCT-534. The company was founded by David F. Hale and James B. Breitmeyer in September 1997 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wills Robert JamesDirectorApr 08 '24Buy8.963,08627,65510,000Apr 10 08:38 PM
Wills Robert JamesDirectorMar 28 '24Buy8.486,91458,6026,914Apr 01 07:00 PM
HALE DAVID FDirectorFeb 23 '24Buy9.047146,455714Feb 27 05:03 PM
HALE DAVID FDirectorFeb 23 '24Buy9.042662,40529,673Feb 27 05:03 PM
Wills Robert JamesDirectorFeb 23 '24Sale9.049808,8590Feb 27 05:02 PM
ANNX - Annexon Inc - Stock Price Chart
TickerANNX [NASD, RUT]
CompanyAnnexon Inc
CountryUSA
IndustryBiotechnology
Market Cap466.60MEPS (ttm)-1.78
P/E-EPS this Y13.88%
Forward P/E-EPS next Y-7.79%
PEG-EPS past 5Y-29.69%
P/S-EPS next 5Y38.60%
P/B1.39EPS Q/Q24.94%
Dividend-Sales Q/Q-
Insider Own21.24%Inst Own66.36%
Insider Trans1.42%Inst Trans11.82%
Short Float4.34%EarningsMar 26/a
Analyst Recom1.00Target Price15.17
Avg Volume1.56M52W Range1.57 - 8.40
Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington's and alzheimer's disease, multiple sclerosis, glaucoma, parkinson's disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3, 2011 and is headquartered in Brisbane, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Carson William H.DirectorApr 08 '24Buy6.073,20019,4113,200Apr 10 07:17 PM
Yednock TedEVP & CHIEF INNOVATION OFFICERFeb 20 '24Sale5.512,60414,34872,471Feb 21 04:31 PM
Lew JenniferEVP & CHIEF FINANCIAL OFFICERFeb 20 '24Sale5.532,59314,33982,058Feb 21 04:31 PM
Overdorf MichaelEVP & CHIEF BUSINESS OFFICERFeb 20 '24Sale5.481,95110,69185,641Feb 21 04:31 PM
Love DouglasPRESIDENT AND CEOFeb 12 '24Sale5.545,78232,032196,121Feb 14 07:56 PM
BRTX - BioRestorative Therapies Inc - Stock Price Chart
TickerBRTX [NASD]
CompanyBioRestorative Therapies Inc
CountryUSA
IndustryBiotechnology
Market Cap9.75MEPS (ttm)-3.54
P/E-EPS this Y37.72%
Forward P/E-EPS next Y1.17%
PEG-EPS past 5Y77.95%
P/S64.99EPS next 5Y-
P/B0.59EPS Q/Q49.37%
Dividend-Sales Q/Q421.62%
Insider Own27.60%Inst Own11.39%
Insider Trans18.21%Inst Trans2.02%
Short Float0.83%Earnings-
Analyst Recom1.00Target Price10.50
Avg Volume657.55K52W Range1.20 - 7.13
BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Silva FranciscoVP of Research and DevelopmentApr 09 '24Buy1.256,6008,250155,759Apr 10 05:16 PM
Silva FranciscoVP of Research and DevelopmentApr 08 '24Buy1.161,7081,979149,159Apr 10 05:16 PM
Broadrick Dale10% OwnerFeb 09 '24Buy1.3286,041113,574477,972Feb 12 09:26 AM
Broadrick Dale10% OwnerFeb 08 '24Buy1.3483,626112,059447,045Feb 09 08:00 AM
Broadrick Dale10% OwnerFeb 08 '24Buy1.2573,95992,449391,931Feb 12 09:26 AM
TRDA - Entrada Therapeutics Inc - Stock Price Chart
TickerTRDA [NASD, RUT]
CompanyEntrada Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap400.18MEPS (ttm)-0.25
P/E-EPS this Y-1152.00%
Forward P/E-EPS next Y-38.78%
PEG-EPS past 5Y-5.52%
P/S3.10EPS next 5Y-
P/B1.64EPS Q/Q63.59%
Dividend-Sales Q/Q-
Insider Own46.49%Inst Own47.87%
Insider Trans-0.05%Inst Trans-0.82%
Short Float9.82%EarningsMar 13/b
Analyst Recom1.00Target Price21.00
Avg Volume76.36K52W Range10.62 - 18.44
Entrada Therapeutics, Inc. operates as a biotechnology company. It focuses on delivery of biomolecules into the cell to treat devastating diseases. The firm offers intracellular enzyme replacement therapy and protein-protein interaction inhibitors programs. The company focuses on creating and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to target and engage underlying drivers of diseases. Entrada Therapeutics was founded by Dehua Pei in September 22, 2016 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KIM PETER SDirectorApr 08 '24Buy13.572,60035,29062,936Apr 10 04:35 PM
KIM PETER SDirectorMar 28 '24Buy13.751,51220,79460,336Apr 01 04:31 PM
KIM PETER SDirectorMar 26 '24Buy13.642,75037,50958,824Mar 26 05:57 PM
KIM PETER SDirectorMar 25 '24Buy13.363,18042,47256,074Mar 26 05:57 PM
KIM PETER SDirectorMar 22 '24Buy13.763,11842,90152,894Mar 26 05:57 PM
DOMH - Dominari Holdings Inc - Stock Price Chart
TickerDOMH [NASD]
CompanyDominari Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap16.60MEPS (ttm)-4.33
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S8.14EPS next 5Y-
P/B0.31EPS Q/Q19.43%
Dividend-Sales Q/Q-
Insider Own14.65%Inst Own7.88%
Insider Trans20.49%Inst Trans16.15%
Short Float0.04%Earnings-
Analyst Recom1.00Target Price16.00
Avg Volume12.05K52W Range1.76 - 3.76
Dominari Holdings, Inc. is a biotechnology development company, which engages in the provision of diversified portfolio of small-molecule anticancer and antiviral therapeutics in development. Its oncology therapeutics includes treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It also creates a broad-spectrum antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wool Kyle MichaelPresidentApr 08 '24Buy2.998,50025,39022,750Apr 10 04:10 PM
Hayes AnthonyCEOApr 05 '24Buy2.8813,50038,823116,248Apr 08 04:10 PM
Wool Kyle MichaelPresidentApr 04 '24Buy2.8719,00054,51118,500Apr 08 04:10 PM
Hayes AnthonyCEOApr 04 '24Buy2.623,94410,339102,748Apr 08 04:10 PM
Devall Christopher FranklinCOODec 26 '23Buy2.557,00017,86330,033Dec 28 08:00 AM
MMLP - Martin Midstream Partners LP - Stock Price Chart
TickerMMLP [NASD]
CompanyMartin Midstream Partners LP
CountryUSA
IndustryOil & Gas Midstream
Market Cap103.74MEPS (ttm)0.09
P/E28.45EPS this Y190.91%
Forward P/E10.23EPS next Y160.00%
PEG7.90EPS past 5Y-
P/S0.14EPS next 5Y3.60%
P/B-EPS Q/Q162.45%
Dividend0.75%Sales Q/Q-26.05%
Insider Own27.84%Inst Own35.33%
Insider Trans2.64%Inst Trans1.12%
Short Float0.22%EarningsApr 17/a
Analyst Recom3.00Target Price3.50
Avg Volume44.96K52W Range1.95 - 3.30
Martin Midstream Partners LP engages in a diverse set of operations focused primarily in the United States Gulf Coast region. It operates through the following segments: Terminalling and Storage, Transportation, Sulfur Services, and Natural Gas Liquids. The Terminalling and Storage segment offers storage, refining, blending, packaging, and handling services for producers and suppliers of petroleum products and by-products, including the refining of naphthenic crude oil and the blending and packaging of various grades and quantities of industrial, commercial, and automotive lubricants and greases. The Transportation segment manages a fleet of inland marine tank barges, inland push boats and offshore tug, and barge unit that transport petroleum products and by-products. The Sulfur Services segment develops an integrated system of transportation assets and facilities relating to sulfur services. The Natural Gas Liquids segment distributes natural gas liquids. The company was founded in 2002 and is headquartered in Kilgore, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BONDURANT ROBERT DPresident and CEOApr 09 '24Buy2.651,6034,243148,070Apr 10 12:57 PM
MARTIN RUBEN SDirectorApr 09 '24Buy2.658212,173158,800Apr 10 12:57 PM
Taylor Sharon LExecutive Vice President / CFOApr 09 '24Buy2.653981,05323,034Apr 10 12:57 PM
Shoup Scot ASenior VP OperationsApr 09 '24Buy2.6517646627,846Apr 10 12:57 PM
BONDURANT ROBERT DPresident and CEOMar 12 '24Buy2.561,1062,829146,467Mar 14 11:07 AM
BSBK - Bogota Financial Corp - Stock Price Chart
TickerBSBK [NASD]
CompanyBogota Financial Corp
CountryUSA
IndustryBanks - Regional
Market Cap88.91MEPS (ttm)0.05
P/E142.46EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-31.37%
P/S2.31EPS next 5Y-
P/B0.65EPS Q/Q-164.57%
Dividend-Sales Q/Q6.62%
Insider Own66.91%Inst Own7.91%
Insider Trans0.38%Inst Trans-3.69%
Short Float0.21%EarningsFeb 06/a
Analyst Recom3.00Target Price12.00
Avg Volume6.08K52W Range6.46 - 9.43
Bogota Financial Corp. is a holding company, which engages in the provision of business activities that are permissible for mutual holding companies under New Jersey law, including investing in loans and securities. It includes the acquisition of banking and financial services companies. It operates through the following loan portfolio: residential first mortgage, commercial and multi-family real estate, construction, home equity and other, and commercial and industrial. The company was founded in September 2019 and is headquartered in Teaneck, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Walsh Robert C.Executive Vice PresidentApr 09 '24Buy6.842501,7104,750Apr 10 12:09 PM
Masterson John J.DirectorMar 15 '24Buy7.301,40010,220172,584Mar 15 05:06 PM
Pace KevinPresident and CEOMar 15 '24Buy7.3012591243,903Mar 18 10:23 AM
Masterson John J.DirectorMar 14 '24Buy7.301,92914,082171,184Mar 15 05:06 PM
Pace KevinPresident and CEOMar 08 '24Buy7.377555243,778Mar 08 05:14 PM
WDI - Western Asset Diversified Income Fund - Stock Price Chart
TickerWDI [NYSE]
CompanyWestern Asset Diversified Income Fund
CountryUSA
IndustryClosed-End Fund - Debt
Market Cap728.14MEPS (ttm)1.12
P/E12.55EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend11.79%Sales Q/Q-
Insider Own-Inst Own30.68%
Insider Trans-Inst Trans-
Short Float0.05%Earnings-
Analyst Recom-Target Price-
Avg Volume200.67K52W Range12.16 - 14.69
Western Asset Diversified Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is to seek high current income. As a secondary investment objective, the Fund seek capital appreciation. Under normal circumstances, the Fund invest across fixed income sectors and securities to deliver a well-diversified portfolio. The Fund may invest in investment-grade and high-yield corporate debt securities, senior loans, agency and non-agency residential mortgage-backed securities (RMBS) and commercial mortgage-backed securities (CMBS), bank loans, collateralized loan obligations (CLOs), asset-backed securities, private debt and mortgage whole loans. The Fund may invest up to 15% of its managed assets in securities issued by CLOs, including up to 5% of its managed assets in equity securities issued by CLOs, including subordinated, or residual tranches of CLO securities). The Fund's investment manager is Legg Mason Partners Fund Advisor, LLC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kumar NishaDirectorApr 08 '24Buy14.466,22590,00613,725Apr 10 11:51 AM
Kumar NishaDirectorJan 23 '24Buy14.097,500105,6757,500Jan 24 06:01 PM
Kumar NishaDirectorJan 22 '24Buy14.169,000127,4409,000Jan 24 06:01 PM
CRONIN DANIEL PDirectorOct 23 '23Buy12.425,00062,1005,000Oct 24 05:03 PM
NXDT - NexPoint Diversified Real Estate Trust - Stock Price Chart
TickerNXDT [NYSE, RUT]
CompanyNexPoint Diversified Real Estate Trust
CountryUSA
IndustryREIT - Diversified
Market Cap242.54MEPS (ttm)-3.26
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S3.93EPS next 5Y-
P/B0.27EPS Q/Q-
Dividend9.54%Sales Q/Q-
Insider Own18.92%Inst Own51.08%
Insider Trans0.55%Inst Trans1.20%
Short Float0.63%Earnings-
Analyst Recom-Target Price-
Avg Volume123.13K52W Range5.82 - 13.07
NexPoint Diversified Real Estate Trust is a real estate investment trust, which engages in the business of acquisition, asset management, development, and disposition of opportunistic, value-add investments in real estate properties. The firm is also involved in investing in various commercial real estate property types and across the capital structure including equity, mortgage debt, mezzanine debt, and preferred equity. The company was founded on March 10, 2006 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LAFFER ARTHUR BDirectorApr 09 '24Buy6.1720,000123,40088,276Apr 10 11:13 AM
LAFFER ARTHUR BDirectorApr 08 '24Buy6.1220,000122,40068,276Apr 10 11:13 AM
DONDERO JAMES DSee RemarksOct 06 '23Buy14.203735,29720,797Oct 10 04:15 PM
DONDERO JAMES DSee RemarksOct 05 '23Buy14.202,08129,55020,424Oct 10 04:15 PM
KAVANAUGH SCOTT FDirectorAug 17 '23Sale10.621,13112,0060Aug 17 04:30 PM
AUBN - Auburn National Bancorp Inc. - Stock Price Chart
TickerAUBN [NASD]
CompanyAuburn National Bancorp Inc.
CountryUSA
IndustryBanks - Regional
Market Cap59.33MEPS (ttm)0.40
P/E42.86EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-30.30%
P/S1.89EPS next 5Y-
P/B0.78EPS Q/Q-189.50%
Dividend6.35%Sales Q/Q-58.43%
Insider Own57.80%Inst Own8.65%
Insider Trans0.04%Inst Trans4.75%
Short Float0.26%Earnings-
Analyst Recom-Target Price-
Avg Volume3.05K52W Range16.80 - 23.75
Auburn National Bancorporation, Inc. is a bank holding company. It engages in the provision of banking services to commercial and retail customers. The firm operates through the following segments: Commercial and Industrial, Construction and Land Development, Commercial Real Estate, Residential Real Estate, and Consumer Installment. The Commercial and Industrial segment includes loans to finance business operations, equipment purchases, or other needs for small and medium-sized commercial customers. The Construction and Land Development segment is comprised of both loans and credit lines for the purpose of purchasing, carrying and developing land into commercial developments or residential subdivisions. The Commercial and Industrial segment provides loans disaggregated into three classes: owner occupied, multi-family and other. The Residential Real Estate segment is involved in consumer mortgage and investment property. The Consumer Installment segment encompasses loans to individuals both secured by personal property and unsecured. The company was founded in 1990 and is headquartered in Auburn, AL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Barrett J TuttDirectorApr 09 '24Buy19.25931,7918,553Apr 10 10:43 AM
HAM WILLIAM F JRDirectorApr 09 '24Buy19.21721,3834,841Apr 10 10:59 AM
HOUSEL DAVID EDirectorApr 09 '24Buy19.25641,2327,345Apr 10 10:27 AM
O'DONNELL SHANNONSenior Vice PresidentApr 09 '24Buy19.28346561,356Apr 10 10:06 AM
Barrett J TuttDirectorJan 02 '24Buy20.85841,7518,460Jan 03 12:23 PM
12345678910